tiprankstipranks
Inoviq Ltd (AU:IIQ)
ASX:IIQ

Inoviq Ltd (IIQ) Share Price & Analysis

0 Followers

IIQ Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.47 - AU$0.99
Previous CloseAU$0.5
Volume180.00
Average Volume (3M)108.69K
Market Cap
AU$45.55M
Enterprise ValueAU$31.15M
Total Cash (Recent Filing)AU$15.39M
Total Debt (Recent Filing)AU$998.69K
Price to Earnings (P/E)-7.0
Beta1.29
Aug 27, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares OutstandingN/A
10 Day Avg. Volume135,233
30 Day Avg. Volume108,690
Standard Deviation0.42
R-Squared0.00634
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

IIQ FAQ

What was Inoviq Ltd’s price range in the past 12 months?
Inoviq Ltd lowest share price was AU$0.47 and its highest was AU$0.99 in the past 12 months.
    What is Inoviq Ltd’s market cap?
    Currently, no data Available
    When is Inoviq Ltd’s upcoming earnings report date?
    Inoviq Ltd’s upcoming earnings report date is Aug 27, 2024 which is in 114 days.
      How were Inoviq Ltd’s earnings last quarter?
      Inoviq Ltd released its earnings results on Feb 22, 2024. The company reported -AU$0.034 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.034.
        Is Inoviq Ltd overvalued?
        According to Wall Street analysts Inoviq Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Inoviq Ltd pay dividends?
          Inoviq Ltd does not currently pay dividends.
          What is Inoviq Ltd’s EPS estimate?
          Inoviq Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Inoviq Ltd have?
          Inoviq Ltd has 92,018,700 shares outstanding.
            What happened to Inoviq Ltd’s price movement after its last earnings report?
            Inoviq Ltd reported an EPS of -AU$0.034 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.317%.
              Which hedge fund is a major shareholder of Inoviq Ltd?
              Currently, no hedge funds are holding shares in AU:IIQ
              ---

              Inoviq Ltd Stock Smart Score

              5
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -10.00%
              12-Months-Change

              Fundamentals

              Return on Equity
              -32.85%
              Trailing 12-Months
              Asset Growth
              -29.16%
              Trailing 12-Months

              Company Description

              Inoviq Ltd

              Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Island Pharmaceuticals Ltd
              Apiam Animal Health Ltd.
              Microba Life Sciences Limited
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis